| HIT | DIC | TTP | ITP | 
|---|---|---|---|
| 
					  Hospitalized patient with clot after week in hospital Type: HIT -1 (antibody present but not clinically significant) HIT - 2 (true HIT) Autoimmune HIT (Rare; usually after major surgery) 
					 Patient presentation? Types of HIT? | 
					  Sepsis (meningococcus, pneumococcus), metabolic stress, obstetrical complications, malignancies APML, burns					 
					 Patient presentation for DIC | 
					  Occurs at any age; peaks in third decade More common in females (60%) 
					 Patient presentation for TTP? | 
					  Children, 2-6, associated with prior viral illness, spontaneous resolution, supportive mgmt Adults, associated with SLE, HIV, thrombocytopenia <20k, mucosal bleeding 
					 Patient presentation for ITP? Acute and chronic form? | 
| 
					  Activated Platelet (by surgery or infection) release PF4 from alpha-granule  PF4/Heparin polyanion complex is formed OR PF4/ Bacteria polyanion complex is formed This complex activates B cell and produce IgG against PF4 Ig G ab - PF4/Polyanion complex is formed This complex binds platelets and activates more platelets - causes increased thrombosis Monocytes also activates them - causes thrombosis Platelet bound with Anti-PF4 ab are removed by splenic macrophages leading to thrombocytopenia Hence, unlike all other cause of thrombocytopenia that causes bleeding, HIT paradoxically causes thrombosis. 
					 Pathology of HIT? | 
					  Release of TF, endothelial damage, endotoxin, exposure of procoagulants from cancer cells. Production of thrombin and activation of fibrinolytic system. Clots using up coagulation factors. 					 
					 Pathology of DIC? | 
					  Normally, endothelial cells produce ultra-large von Willebrand factor (vWF) multimers which is cleaved by ADAMTS13  With deficiency, large vWF multimers are in circulation, bind platelets and cause microthrombi in circulation • Can be enhanced by other factors (drugs, hypertension, post-partum) that damage endothelial cells 
					 Mechanism of TTP? | 
					  Acquired autoimmune disorder, antibodies against platelet membrane glycoproteins from meds, viral infection, pregnancy, autoimmune disorders					 
					 Pathology of ITP? | 
| 
					  4T scoring (0-2 point for each) NEJM 2015 Acute Thrombocytopenia (usually >20K) 10 % have decrease in platelet count of 30-50% Timing of Onset (Day 5-10, <5 days, >10 days) Only exception is if patient was on heparin in near past. Rapid-onset HIT (within 30 min) Delayed-onset HIT (unto 3 weeks after) New Thrombosis VTE occurs in 50% of confirmed HIT Alternative cause of thrombocytopenia (DIC, Drugs etc) Score: 6-8: High probability. Order further tests. 4-5: Intermediate score. <3 : 5% probability. 
					 Diagnostic criteria? 4T? | 
					  Platelets Low Fibrinogen Low D-Dimer Increased PT/PTT Increased FVIII Decreased MAHA Schistocytes 
					 Labs in DIC | 
					  • Fever • Microangiopathic hemolytic anemia • Thrombocytopenia • Renal abnormalities • Neurological changes 
					 What is the TTP clinical pentad? | 
					  Thrombocytopenia with normal marrow Diangosis of exclusion, PT and PTT normal 
					 Diagnosis of ITP? | 
| 
					  Screen: ELISA ab.  If positive, reflexively, optical density test for quantification. If that is positive, Serotonin Release Assay (SRA) Gold standard for diagnosis. Negative SRA does not exclude HIT 
					 How do we test for HIT? | 
					  Treat underlying cause • Supportive care (maintain BP, etc.) • Replacement therapy for bleeding (FFP, cryoprecipitate and platelet transfusions) 
					 Treatment of DIC | 
					  • Schistocytes -Intravascular hemolysis – peripheral smear • Platelets < 20K • Increased reticulocyte count • Increased indirect bilirubin • Increased LDH • Decreased haptoglobin FIBRINOGEN AND D-DIMER NORMAL-HYALINE CLOT 
					 Labs for TTP? | 
					  Steroids –reduce the rate of platelet destruction • Other immunosuppressive drugs (eg, rituximab) • IVIG – Intravenous Immuno(gamma) globulin • Rh Immune globulin (RhoGAM) – Spleen removes Ab coated RBCs from circulation rather than plt (in RH + people) • Splenectomy • Stop suspected medicine if possible • Treat infection • Thrombopoiesis-stimulating drugs offer a new treatment option • Plt (if life threatening) 
					 Treatment of ITP? | 
| 
					  Direct Thrombin Inhibitor Lepirudin (FDA approved) Argatroban (FDA approved) Off label use of Fondaparinaux as Fondaperinaux does not have moiety to cause antibody production, yet can activate anti-thrombin. Use therapeutic dose anti-coagulation until platelet > 150K for 2 consecutive days. Avoid the use of warfarin. Decrease APC, procoag. 
					 Treatment? | 
					  DIC with fibrin strands in small BVs that slice up the RBCs • Schistocytes also present in TTP and HUS; also present in artificial heart valves; also seen in APML (acute promyelocytic leukemia) 
					 Where else can we find schistocytes? | 
					  PLEX 1.5 volumes x 5 days (PLASMIC SCORE >=6) FFP 2 units Steroids (60mg pred, 125 sol) 
					 TTP treatment? | 
					  Keep it chillllllllllll					 
					 My favorite phrase? |